These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7117371)

  • 1. Differences among 'serotonergic' anorectics in a cross-tolerance paradigm: do they all act on serotonin systems?
    Rowland N; Antelman SM; Kocan D
    Eur J Pharmacol; 1982 Jun; 81(1):57-66. PubMed ID: 7117371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different behavioral mechanisms underlie tolerance to the anorectic effects of fenfluramine and quipazine.
    Rowland N; Carlton J
    Psychopharmacology (Berl); 1983; 81(2):155-7. PubMed ID: 6415747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anorexia and brain serotonin: development of tolerance to the effects of fenfluramine and quipazine in rats with serotonin-depleting lesions.
    Carlton J; Rowland N
    Pharmacol Biochem Behav; 1984 May; 20(5):739-45. PubMed ID: 6610879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of fenfluramine and other anorectic agents in different feeding and drinking paradigms in rats.
    Rowland NE; Antelman SM; Bartness TJ
    Life Sci; 1985 Jun; 36(24):2295-300. PubMed ID: 4010458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chronic administration of fenfluramine and quipazine on body weight gain after ovariectomy and on brain serotonin receptor binding.
    Rowland N; Carlton J; Bartness T; Smith G
    Behav Neurosci; 1983 Jun; 97(3):502-5. PubMed ID: 6683563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for 5-HT2 receptor mediation in quipazine anorexia.
    Shukla R; MacKenzie-Taylor D; Rech RH
    Psychopharmacology (Berl); 1990; 100(1):115-8. PubMed ID: 2296618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical and behavioral factors in the development of tolerance to anorectics.
    Streather A; Hinson RE
    Behav Neurosci; 1985 Oct; 99(5):842-52. PubMed ID: 3843304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible involvement of endogenous opiates in the tolerance to the anorectic effect of fenfluramine.
    Groppetti A; Parenti M; Dellavedova L; Tirone F
    J Pharmacol Exp Ther; 1984 Feb; 228(2):446-53. PubMed ID: 6694120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that it is possible to cause anorexia by increasing release and/or directly stimulating postsynaptic serotonin receptors in the brain.
    Samanin R; Mennini T; Garattini S
    Prog Neuropsychopharmacol; 1980; 4(4-5):363-9. PubMed ID: 7220662
    [No Abstract]   [Full Text] [Related]  

  • 10. Sleep suppressant action of fenfluramine in rats. II. Evidence against the involvement of presynaptic serotonergic mechanism.
    Fornal C; Radulovacki M
    J Pharmacol Exp Ther; 1983 Jun; 225(3):675-81. PubMed ID: 6223135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action of fenfluramine, phenylpropanolamine, phentermine and diethylpropion on acoustic startle in rats.
    Kutscher CL
    Pharmacol Biochem Behav; 1987 Aug; 27(4):749-52. PubMed ID: 3659098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anorectic effect of fenfluramine isomers and metabolites: relationship between brain levels and in vitro potencies on serotonergic mechanisms.
    Mennini T; Garattini S; Caccia S
    Psychopharmacology (Berl); 1985; 85(1):111-4. PubMed ID: 2984709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic anorexic and behavioural effects of the fenfluramine metabolite, norfenfluramine: an evaluation of its role in the actions of fenfluramine.
    Goudie AJ; Taylor M; Wheeler TJ
    Psychopharmacologia; 1974; 38(1):67-74. PubMed ID: 4851021
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of initial body weight on anorexia and tolerance to fenfluramine in rats.
    Carlton J; Rowland N
    Pharmacol Biochem Behav; 1985 Oct; 23(4):551-4. PubMed ID: 4070331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulus generalization by fenfluramine in a quipazine-ketanserin drug discrimination is not dependent on indirect serotonin release.
    Smith RL; Gresch PJ; Barrett RJ; Sanders-Bush E
    Pharmacol Biochem Behav; 2002 May; 72(1-2):77-85. PubMed ID: 11900772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the mechanisms of tolerance to the anorectic effect of salbutamol in rats.
    Bendotti C; Borsini F; Samanin R
    Eur J Pharmacol; 1983 Sep; 92(3-4):237-42. PubMed ID: 6138263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurochemical mechanism of action of drugs which modify feeding via the serotoninergic system.
    Garattini S; Mennini T; Bendotti C; Invernizzi R; Samanin R
    Appetite; 1986; 7 Suppl():15-38. PubMed ID: 2427023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of depletion of brain serotonin by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine.
    Kleven MS; Schuster CR; Seiden LS
    J Pharmacol Exp Ther; 1988 Sep; 246(3):822-8. PubMed ID: 2458447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two novel agents affecting eating through an action on monoaminergic systems.
    Roncucci R; Miranda GF; Verry M
    Int J Obes; 1984; 8 Suppl 1():103-17. PubMed ID: 6549508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerance and cross tolerance to the anorexigenic effect of appetite suppressants in rats.
    Opitz K
    Int J Obes; 1978; 2(1):59-68. PubMed ID: 711356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.